83 FR 33943 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 138 (July 18, 2018)

Page Range		33943-33943
FR Document		2018-15279

Federal Register, Volume 83 Issue 138 (Wednesday, July 18, 2018)

[Federal Register Volume 83, Number 138 (Wednesday, July 18, 2018)]
[Notices]
[Page 33943]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-15279]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Center for Genetic Studies (7797).
    Date: July 25, 2018.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, National Institute 
on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, 
Bethesda, MD 20892-9550, 301-827-5819, gm145a@nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: July 12, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-15279 Filed 7-17-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 138 / Wednesday, July 18, 2018 / Notices 33943

Name of Committee: National Institute of Boulevard, Bethesda, MD 20892 (Telephone Dated: July 12, 2018.
Diabetes and Digestive and Kidney Diseases Conference Call). Ronald J. Livingston, Jr.,
Special Emphasis Panel; Sleep Apnea Contact Person: Ann A. Jerkins, Ph.D.,
Treatment With Positive Airway Pressure for Program Analyst, Office of Federal Advisory
Scientific Review Officer, Review Branch,
Prevention of Diabetes Mellitus. Committee Policy/
DEA, NIDDK, National Institutes of Health,
Date: July 27, 2018. Room 7119, 6707 Democracy Boulevard, [FR Doc. 2018–15280 Filed 7–17–18; 8:45 am]
Time: 1:00 p.m. to 2:00 p.m. Bethesda, MD 20892–5452, 301–594–2242, BILLING CODE 4140–01–P
Agenda: To review and evaluate grant
jerkinsa@niddk.nih.gov.
applications.
Place: National Institutes of Health, Two Name of Committee: National Institute of
Democracy Plaza, 6707 Democracy Diabetes and Digestive and Kidney Diseases DEPARTMENT OF HEALTH AND
Boulevard, Bethesda, MD 20892 (Telephone Special Emphasis Panel; Time-Sensitive HUMAN SERVICES
Conference Call). Obesity Research.
Contact Person: Paul A. Rushing, Ph.D., Date: August 8, 2018. National Institutes of Health
Scientific Review Officer, Review Branch, Time: 1:00 p.m. to 3:00 p.m.
DEA, NIDDK, National Institutes of Health, Agenda: To review and evaluate grant National Institute on Drug Abuse;
Room 7345, 6707 Democracy Boulevard, applications. Notice of Closed Meeting
Bethesda, MD 20892–5452, (301) 594–8895, Place: National Institutes of Health, Two
rushingp@extra.niddk.nih.gov. Pursuant to section 10(d) of the
Democracy Plaza, 6707 Democracy
This notice is being published less than 15 Boulevard, Bethesda, MD 20892 (Telephone Federal Advisory Committee Act, as
days prior to the meeting due to the timing Conference Call). amended, notice is hereby given of the
limitations imposed by the review and Contact Person: Michele L. Barnard, Ph.D., following meeting.
funding cycle.
Scientific Review Officer, Review Branch,
Name of Committee: National Institute of The meeting will be closed to the
DEA, NIDDK, National Institutes of Health,
Diabetes and Digestive and Kidney Diseases Room 7353, 6707 Democracy Boulevard,
public in accordance with the
Special Emphasis Panel; Bariatric Surgery-
Bethesda, MD 20892–2542, (301) 594–8898, provisions set forth in sections
Related Applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
barnardm@extra.niddk.nih.gov.
Date: July 30, 2018. as amended. The contract proposals and
Time: 2:00 p.m. to 3:00 p.m. Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases the discussions could disclose
Agenda: To review and evaluate grant
applications. Special Emphasis Panel; RFA–DK–17–030 confidential trade secrets or commercial
Place: National Institutes of Health, Two Advancement of Cell Replacement Therapies property such as patentable material,
Democracy Plaza, 6707 Democracy for Type 1 Diabetes (R43/R44). and personal information concerning
Boulevard, Bethesda, MD 20892 (Telephone Date: August 8, 2018. individuals associated with the contract
Conference Call). Time: 12:30 p.m. to 4:30 p.m. proposals, the disclosure of which
Contact Person: Paul A. Rushing, Ph.D., Agenda: To review and evaluate grant would constitute a clearly unwarranted
Scientific Review Officer, Review Branch, applications. invasion of personal privacy.
DEA, NIDDK, National Institutes of Health, Place: National Institutes of Health, Two
Room 7345, 6707 Democracy Boulevard, Democracy Plaza, 6707 Democracy Name of Committee: National Institute on
Bethesda, MD 20892–5452, (301) 594–8895, Boulevard, Bethesda, MD 20892 (Telephone Drug Abuse Special Emphasis Panel, Center
rushingp@extra.niddk.nih.gov. for Genetic Studies (7797).
Conference Call).
This notice is being published less than 15 Contact Person: Ann A. Jerkins, Ph.D., Date: July 25, 2018.
days prior to the meeting due to the timing Scientific Review Officer, Review Branch, Time: 12:00 p.m. to 3:00 p.m.
limitations imposed by the review and DEA, NIDDK, National Institutes of Health, Agenda: To review and evaluate contract
funding cycle. proposals.
Room 7119, 6707 Democracy Boulevard,
Name of Committee: National Institute of Bethesda, MD 20892–5452, 301–594–2242, Place: National Institutes of Health,
Diabetes and Digestive and Kidney Diseases jerkinsa@niddk.nih.gov. Neuroscience Center, 6001 Executive
Special Emphasis Panel; Type 1 Diabetes
Name of Committee: National Institute of Boulevard, Rockville, MD 20852 (Telephone
Small Business Applications.
Date: August 6, 2018. Diabetes and Digestive and Kidney Diseases Conference Call).
Time: 2:00 p.m. to 5:00 p.m. Special Emphasis Panel; NIDDK–R01 Contact Person: Gerald L. McLaughlin,
Agenda: To review and evaluate grant Telephone Review. Ph.D., Scientific Review Officer, Office of
applications. Date: August 10, 2018. Extramural Policy and Review, National
Place: National Institutes of Health, Two Time: 11:00 a.m. to 3:00 p.m. Institute on Drug Abuse, NIH, DHHS, 6001
Democracy Plaza, 6707 Democracy Agenda: To review and evaluate grant Executive Blvd., Room 4238, MSC 9550,
Boulevard, Bethesda, MD 20892 (Telephone applications. Bethesda, MD 20892–9550, 301–827–5819,
Conference Call). Place: National Institutes of Health, Two gm145a@nih.gov.
Contact Person: Ryan G. Morris, Ph.D., Democracy Plaza, 6707 Democracy
Scientific Review Officer, Review Branch, This notice is being published less than 15
Boulevard, Bethesda, MD 20892 (Telephone
DEA, NIDDK, National Institutes of Health, days prior to the meeting due to the timing
Conference Call).
Room 7015, 6707 Democracy Boulevard, limitations imposed by the review and
Contact Person: Xiaodu Guo, MD, Ph.D.,
Bethesda, MD 20892–2542, 301–594–4721, funding cycle.
Scientific Review Officer, Review Branch,
ryan.morris@nih.gov. DEA, NIDDK, National Institutes of Health, (Catalogue of Federal Domestic Assistance
Name of Committee: National Institute of Room 7023, 6707 Democracy Boulevard, Program No.: 93.279, Drug Abuse and
Diabetes and Digestive and Kidney Diseases Bethesda, MD 20892–5452, (301) 594–4719, Addiction Research Programs, National
Special Emphasis Panel; RFA–DK–17–035 guox@extra.niddk.nih.gov. Institutes of Health, HHS)
amozie on DSK3GDR082PROD with NOTICES1

Microphysiological Systems (MPS) for
Modeling Diabetes (UG3/UH3). (Catalogue of Federal Domestic Assistance Dated: July 12, 2018.
Date: August 7, 2018. Program Nos. 93.847, Diabetes,
Natasha M. Copeland,
Time: 11:30 a.m. to 3:30 p.m. Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition Program Analyst, Office of Federal Advisory
Agenda: To review and evaluate
Research; 93.849, Kidney Diseases, Urology Committee Policy.
cooperative agreement applications.
Place: National Institutes of Health, Two and Hematology Research, National Institutes [FR Doc. 2018–15279 Filed 7–17–18; 8:45 am]
Democracy Plaza, 6707 Democracy of Health, HHS) BILLING CODE 4140–01–P

VerDate Sep<11>2014 19:19 Jul 17, 2018 Jkt 244001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\18JYN1.SGM 18JYN1

Document Created: 2018-11-06 10:24:44
Document Modified: 2018-11-06 10:24:44

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 25, 2018.
FR Citation		83 FR 33943

83 FR 33943 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 138 (July 18, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health